- Home
- VNDA vs ISPR Comparison
VNDA vs ISPR Comparison
Compare VNDA & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- ISPR
- Stock Information
- Founded
- VNDA 2002
- ISPR 2019
- Country
- VNDA United States
- ISPR United States
- Employees
- VNDA N/A
- ISPR N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- ISPR Medicinal Chemicals and Botanical Products
- Sector
- VNDA Health Care
- ISPR Health Care
- Exchange
- VNDA Nasdaq
- ISPR Nasdaq
- Market Cap
- VNDA 282.8M
- ISPR 275.7M
- IPO Year
- VNDA 2006
- ISPR 2023
- Fundamental
- Price
- VNDA $4.99
- ISPR $3.15
- Analyst Decision
- VNDA Strong Buy
- ISPR Strong Buy
- Analyst Count
- VNDA 2
- ISPR 1
- Target Price
- VNDA $16.50
- ISPR $12.50
- AVG Volume (30 Days)
- VNDA 673.5K
- ISPR 45.0K
- Earning Date
- VNDA 05-07-2025
- ISPR 05-13-2025
- Dividend Yield
- VNDA N/A
- ISPR N/A
- EPS Growth
- VNDA N/A
- ISPR N/A
- EPS
- VNDA N/A
- ISPR N/A
- Revenue
- VNDA $198,772,000.00
- ISPR $148,524,656.00
- Revenue This Year
- VNDA $14.36
- ISPR $6.22
- Revenue Next Year
- VNDA $44.53
- ISPR $36.16
- P/E Ratio
- VNDA N/A
- ISPR N/A
- Revenue Growth
- VNDA 3.18
- ISPR 5.10
- 52 Week Low
- VNDA $3.71
- ISPR $2.90
- 52 Week High
- VNDA $6.75
- ISPR $9.89
- Technical
- Relative Strength Index (RSI)
- VNDA 57.32
- ISPR 18.96
- Support Level
- VNDA $4.84
- ISPR $4.20
- Resistance Level
- VNDA $5.16
- ISPR $4.08
- Average True Range (ATR)
- VNDA 0.23
- ISPR 0.33
- MACD
- VNDA 0.02
- ISPR -0.11
- Stochastic Oscillator
- VNDA 66.10
- ISPR 12.02
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.